Anticancer and cytotoxic effects of a triorganotin compound with 2-mercapto-nicotinic acid in malignant cell lines and tumor bearing Wistar rats

European Journal of Pharmaceutical Sciences

Volumn 42, Issue 3, 2011, Pages 253-261

  Verginadis, Ioannis I ^a   Karkabounas, Spyridon ^a   Simos, Yannis ^a   Kontargiris, Evangelos ^a   Hadjikakou, Sotiris K ^b   Batistatou, Anna ^a   Evangelou, Angelos ^a   Charalabopoulos, Konstantinos ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Anticancer drugs; Apoptosis; Cytotoxicity; Tin complexes; Triorganotin

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; NICOTINIC ACID DERIVATIVE; ORGANOTIN COMPOUND; TRIORGANOTIN 2 MERCAPTO NICOTINIC ACID COMPLEX; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CYTOTOXICITY; DNA FRAGMENTATION; DRUG EFFECT; DRUG STRUCTURE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEIOMYOSARCOMA; LUNG TOXICITY; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE AGGREGATION; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; FLOW CYTOMETRY; HUMANS; NEOPLASMS, EXPERIMENTAL; NICOTINIC ACIDS; ORGANOTIN COMPOUNDS; PLATELET AGGREGATION; RATS; RATS, WISTAR; SULFHYDRYL COMPOUNDS;

EID: 79251593444     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2010.11.015     Document Type: Article

References (40)

1. M.A. Abdellah, S.K. Hadjikakou, N. Hadjiliadis, M. Kubicki, T. Bakas, N. Kourkoumelis, Y.V. Simos, S. Karkabounas, M.M. Barsan, and I.S. Butler Synthesis, characterization, and biological studies of organotin(IV) derivatives with o- or p-hydroxybenzoic acids Bioinorg. Chem. Appl. 2009 542979
2. A. Avdikos, S. Karkabounas, A. Metsios, O. Kostoula, K. Havelas, J. Binolis, I. Verginadis, G. Hatziaivazis, I. Simos, and A. Evangelou Anticancer effects on leiomyosarcoma-bearing Wistar rats after electromagnetic radiation of resonant radiofrequencies Hell. J. Nucl. Med. 10 2007 95 101
3. K.A. Baken, J. Arkusz, J.L. Pennings, R.J. Vandebriel, and H. van Loveren In vitro immunotoxicity of bis(tri-n-butyltin)oxide (TBTO) studied by toxicogenomics Toxicology 237 2007 35 48
4. V.I. Balas, S.K. Hadjikakou, N. Hadjiliadis, N. Kourkoumelis, M.E. Light, M. Hursthouse, A.K. Metsios, and S. Karkabounas Crystal structure and antitumor activity of the novel zwitterionic complex of tri-n-butyltin(IV) with 2-thiobarbituric acid Bioinorg. Chem. Appl. 2008 654137
5. F. Barbieri, M. Viale, F. Sparatore, A. Favre, M. Cagnoli, C. Bruzzo, F. Novelli, and A. Alama Cytotoxicity in vitro and preliminary antitumor activity in vivo of a novel organotin compound Anticancer Res. 20 2000 977 980
6. F. Barbieri, F. Sparatore, M. Cagnoli, C. Bruzzo, F. Novelli, and A. Alama Antiproliferative activity and interactions with cell-cycle related proteins of the organotin compound triethyltin(IV) lupinylsulfide hydrochloride Chem. Biol. Interact. 134 2001 27 39
7. F. Barbieri, M. Viale, F. Sparatore, G. Schettini, A. Favre, C. Bruzzo, F. Novelli, and A. Alama Antitumor activity of a new orally active organotin compound: a preliminary study in murine tumor models Anticancer Drugs 13 2002 599 604
8. R. Besser, G. Krämer, R. Thümler, J. Bohl, L. Gutmann, and H.C. Hopf Acute trimethyltin limbic-cerebellar syndrome Neurology 37 1987 945 950
9. K. Charalabopoulos, S. Karkabounas, E. Ioachim, V. Papalimneou, K. Syrigos, A. Evangelou, N. Agnantis, and N. Hadjiliadis Antitumour and toxic effects on Wistar rats of two new platinum complexes Eur. J. Clin. Invest. 32 2002 129 133
10. C.T. Chasapis, S.K. Hadjikakou, A. Garoufis, N. Hadjiliads, T. Bakas, M. Kubicki, and Y. Ming Organotin(IV) derivatives of l-cysteine and their in vitro anti-tumor properties Bioinorg. Chem. Appl. 2 2004 43 54
11. M. Chauhan, K. Banerjee, and F. Arjmand DNA binding studies of novel copper(II) complexes containing l-tryptophan as chiral auxiliary: in vitro antitumor activity of Cu-Sn2 complex in human neuroblastoma cells Inorg. Chem. 46 2007 3072 3082
12. M.R. Cookson, N.D. Slamon, and V.W. Pentreath Glutathione modifies the toxicity of triethyltin and trimethyltin in C6 glioma cells Arch. Toxicol. 72 1998 197 202
13. M.A. Costa, L. Pellerito, V. Izzo, T. Fiore, C. Pellerito, M. Melis, M.T. Musmeci, and G. Barbieri Diorganotin(IV) and triorganotin(IV) complexes of meso-tetra(4-sulfonatophenyl)porphine induce apoptosis in A375 human melanoma cells Cancer Lett. 238 2006 284 294
14. A. Eastman Alkylating and platinum-based agents Curr. Opin. Oncol. 2 1990 1109 1114
15. K.D. Ehman, P.M. Phillips, K.L. McDaniel, S. Barone Jr., and V.C. Moser Evaluation of developmental neurotoxicity of organotins via drinking water in rats: dimethyl tin Neurotoxicol. Teratol. 29 2007 622 633
16. N. Einhorn, C. Tropé, M. Ridderheim, K. Boman, B. Sorbe, and E. Cavallin-Sthl A systematic overview of radiation therapy effects in cervical cancer (cervix uteri) Acta Oncol. 42 2003 546 556 (Pubitemid 37193843)
17. A. Evangelou, S. Karkabounas, G. Kalpouzos, M. Malamas, R. Liasko, D. Stefanou, A.T. Vlahos, and T.A. Kabanos Comparison of the therapeutic effects of two vanadium complexes administered at low dose on benzo[a]pyrene-induced malignant tumors in rats Cancer Lett. 119 1997 221 225
18. N. Gerasimchuk, T. Maher, P. Durham, K.V. Domasevitch, J. Wilking, and A. Mokhir Tin(IV) cyanoximates: synthesis, characterization, and cytotoxicity Inorg. Chem. 46 2007 7268 7284
19. M. Gielen Tin-based antitumor drugs: new developments Met. Based Drugs 2 1995 99 103
20. M. Gielen, and E.R.T. Tiekink Tin compounds and their therapeutic potential M. Gielen, E.R.T. Tiekink, Metallotherapeutic Drugs and Metal-based Diagnostic Agents: The Use of Metals in Medicine 2005 John Wiley & Sons West Sussex, England 421 439
21. S.K. Hadjikakou, I.I. Ozturk, M.N. Xanthopoulou, P.C. Zachariadis, S. Zartilas, S. Karkabounas, and N. Hadjiliadis Synthesis, structural characterization and biological study of new organotin(IV), silver(I) and antimony(III) complexes with thioamides J. Inorg. Biochem. 102 2008 1007 1015
22. N. Höti, D.E. Zhu, Z. Song, Z. Wu, S. Tabassum, and M. Wu p53-dependent apoptotic mechanism of a new designer bimetallic compound tri-phenyl tin benzimidazolethiol copper chloride (TPT-CuCl2): in vivo studies in Wistar rats as well as in vitro studies in human cervical cancer cells J. Pharmacol. Exp. Ther. 311 2004 22 33
23. J.A. Houghton Apoptosis and drug response Curr. Opin. Oncol. 11 1999 475 481
24. B. Koch, T.S. Baul, and A. Chatterjee Cell proliferation inhibition and antitumor activity of novel alkyl series of diorganotin(IV) compounds J. Appl. Toxicol. 28 2008 430 438
25. B. Koch, T.S. Basu Baul, and A. Chatterjee p53-dependent antiproliferative and antitumor effect of novel alkyl series of diorganotin(IV) compounds Invest. New Drugs 27 2009 319 326
26. L. Kyros, N. Kourkoumelis, M. Kubicki, L. Male, M.B. Hursthouse, I.I. Verginadis, E. Gouma, S. Karkabounas, K. Charalabopoulos, and S.K. Hadjikakou Structural properties, cytotoxicity, and anti-inflammatory activity of silver(I) complexes with tris(p-tolyl)phosphine and 5-chloro-2-mercaptobenzothiazole Bioinorg. Chem. Appl. 2010 386860
27. K. Lazarou, B. Bednarz, M. Kubicki, I.I. Verginadis, K. Charalabopoulos, N. Kourkoumelis, and S.K. Hadjikakou Structural, photolysis and biological studies of the bis(l2-chloro)-tris(triphenylphosphine)-di-copper(I) and chloro-tris(triphenylphosphine)-copper(I) complexes. Study of copper(I)-copper(I) interactions Inorg. Chim. Acta 363 2010 763 772
28. I.C. Mendes, J.P. Moreira, J.D. Ardisson, R.G. Santos, P.R. da Silva, I. Garcia, A. Castiñeiras, and H. Beraldo Organotin(IV) complexes of 2-pyridineformamide-derived thiosemicarbazones: antimicrobial and cytotoxic effects Eur. J. Med. Chem. 43 2008 1454 1461
29. L. Pellerito, and L. Nagy Organotin(IV)(n+) complexes formed with biologically active ligands: equilibrium and structural studies, and some biological aspects Coord. Chem. Rev. 224 2002 111 150
30. A. Perez-Rebolledo, J.D. Ayala, G.M. de Lima, N. Marchini, G. Bombieri, C.L. Zani, E.M. Souza-Fagundes, and H. Beraldo Structural studies and cytotoxic activity of N(4)-phenyl-2-benzoylpyridine thiosemicarbazone Sn(IV) complexes Eur. J. Med. Chem. 40 2005 467 472
31. A. Savarese, and F. Cognetti New drugs in the treatment of recurrent or metastatic cervical cancer Crit. Rev. Oncol. Hematol. 48 2003 323 327
32. A. Sen, and T.K. Chaudhuri Synthesis and evaluation of dimethyl tin 4-cyclohexyl thiosemicarbazone as a novel antitumor agent Exp. Oncol. 31 2009 22 26
33. N.J. Snoeij, A.A. van Iersel, A.H. Penninks, and W. Seinen Toxicity of triorganotin compounds: comparative in vivo studies with a series of trialkyltin compounds and triphenyltin chloride in male rats Toxicol. Appl. Pharmacol. 81 1985 274 286
34. C. Syng-Ai, T.S. Basu Baul, and A. Chatterjee Inhibition of cell proliferation and antitumor activity of a novel organotin compound J. Environ. Pathol. Toxicol. Oncol. 20 2001 333 342
35. C. Syng-ai, T.S. Basu Baul, and A. Chatterjee Antiproliferative and cytotoxic effect of a novel organotin compound on mammalian cells both in vitro and in vivo Mutat. Res. 513 2002 49 59
36. K. Wu, and B. Bonavida The activated NF-kappaB-Snail-RKIP circuitry in cancer regulates both the metastatic cascade and resistance to apoptosis by cytotoxic drugs Crit. Rev. Immunol. 29 2009 241 254
37. M.N. Xanthopoulou, S.K. Hadjikakou, N. Hadjiliadis, M. Schürmann, K. Jurkschat, A. Michaelides, S. Skoulika, T. Bakas, J. Binolis, S. Karkabounas, and K. Charalabopoulos Synthesis, structural characterization and in vitro cytotoxicity of organotin(IV) derivatives of heterocyclic thioamides, 2-mercaptobenzothiazole, 5-chloro-2-mercaptobenzothiazole, 3-methyl-2- mercaptobenzothiazole and 2-mercaptonicotinic acid J. Inorg. Biochem. 96 2003 425 434
38. M.N. Xanthopoulou, S.K. Hadjikakou, N. Hadjiliadis, M. Schurmann, K. Jurkschat, J. Binolis, S. Karkabounas, and K. Charalabopoulos Synthesis of a novel triphenyltin(IV) derivative of 2-mercaptonicotinic acid with potent cytotoxicity in vitro Bioinorg. Chem. Appl. 1 2003 227 231
39. M.N. Xanthopoulou, S.K. Hadjikakou, N. Hadjiliadis, E.R. Milaeva, J.A. Gracheva, Y. Tyurin, N. Kourkoumelis, K.C. Christoforidis, A.K. Metsios, S. Karkabounas, and K. Charalabopoulos Biological studies of new organotin(IV) complexes of thioamide ligands Eur. J. Med. Chem. 43 2008 327 335
40. P.R. Yallapragada, P.J. Vig, P.R. Kodavanti, and D. Desaiah In vivo effects of triorganotins on calmodulin activity in rat brain J. Toxicol. Environ. Health 34 1991 229 237